Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Shaw

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Virus Research|September 8, 2004
Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortantsThomas Palker, Irina Kiseleva, Kimberly Johnston, et al.
The Journal of Pediatrics|February 5, 2004
Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infantsH Fred Clark, David I Bernstein, Penelope H Dennehy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2006
Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complexYimin Wu, Craig Przysiecki, Elizabeth Flanagan, et al.
The Journal of Infectious Diseases|November 1, 2003
Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccineMyron J Levin, Jeffrey G Smith, Robin M Kaufhold, et al.
Vaccine|July 20, 2002
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy childrenYu-Lung Lau, S J Rupert Vessey, Ivan S F Chan, et al.
Journal of Medical Virology|May 29, 2009
A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnosesRuth Harbecke, Michael N Oxman, Beth A Arnold, et al.
The Lancet. Oncology|March 28, 2025
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort studyAmyn Bhamani, Andrew Creamer, Priyam Verghese, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Virus Research|September 8, 2004
Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortantsThomas Palker, Irina Kiseleva, Kimberly Johnston, et al.
The Journal of Pediatrics|February 5, 2004
Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infantsH Fred Clark, David I Bernstein, Penelope H Dennehy, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2006
Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complexYimin Wu, Craig Przysiecki, Elizabeth Flanagan, et al.
The Journal of Infectious Diseases|November 1, 2003
Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccineMyron J Levin, Jeffrey G Smith, Robin M Kaufhold, et al.
Vaccine|July 20, 2002
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy childrenYu-Lung Lau, S J Rupert Vessey, Ivan S F Chan, et al.
Journal of Medical Virology|May 29, 2009
A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnosesRuth Harbecke, Michael N Oxman, Beth A Arnold, et al.
The Lancet. Oncology|March 28, 2025
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort studyAmyn Bhamani, Andrew Creamer, Priyam Verghese, et al.
Pageof 4